Celecoxib reduces fluidity and decreases metastatic potential of colon cancer cell lines irrespective of COX-2 expression

Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy

(2010) Nihal Simsek Ozek et al.   ANALYST

FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line

(2010) Régis Gasper et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Determination of simvastatin-induced changes in bone composition and structure by Fourier transform infrared spectroscopy in rat animal model

(2010) Sebnem Garip et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer

(2010) S Danese et al.   ONCOGENE

15-Lipoxygenase-1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT-116 and HT-29

(2009) Ismail Çimen et al.   CANCER SCIENCE

Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles

(2009) Asli Sade et al.   JOURNAL OF LIPOSOME RESEARCH

Fourier transform infrared spectroscopic studies of T-cell lymphoma, B-cell lymphoid and myeloid leukaemia cell lines

(2008) Jaspreet Babrah et al.   ANALYST

COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro

(2008) Huan-Ching Chuang et al.   Molecular Cancer

Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression

(2007) C Dianzani et al.   BRITISH JOURNAL OF PHARMACOLOGY